BioCryst Pharmaceuticals, Inc.

BCRXNASDAQ Global Select·USD·Closed

BCRXNASDAQ·USD·Closed

$8.98

−2.81%

$8.98

−$0.26 (2.81%)

52W Range

57thpctl

Volume

0.58×avg

Mkt Cap

2.28BUSD

P/E

-5.3TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

57thpctl

Volume

0.58×avg

Market Cap

2.28BUSD

P/E Ratio

-5.3TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+36.0% / yr

Operating margin-43.1%

ROIC-122.0%

Financially safe

Stretched

Debt / equity-1.55×

Interest coverage-5.1×

Current ratio1.91×